StemCell Therapy

Special to the Journal

Hinghams Ryan Enright was diagnosed with a unique form of diabetes, known as latent autoimmune diabetes in adults (LADA), in 2010 and this year, Enright will be running his 20th Boston Marathon for Joslin Diabetes Center, where he receives his diabetes care from Dr. Elena Toschi.

Since being diagnosed six years ago, the 44-year-old has learned how to manage and cope with his diabetes with the help of the doctors, educators and staff at Joslin, which is especially important for a seasoned marathoner.

Enright is running 40-50 miles each week in preparation for his 25th marathon, doing his long runs on the weekends in Hingham and logging miles along the Charles River during the week. He wears a continuous glucose monitor (CGM) to monitor his blood sugar levels as he runs, and has had to experiment with the settings to ensure he does not go high or low as his distances increase.

My hope is that the funds I raise will benefit Joslin and their team of researchers in their battle to find a cure, said Enright. This is a very specialyear for me given that it will be my 20th consecutive Boston Marathon and I am so grateful that I have the resources at Joslin who make it possible for me to make that left on Boylston Street and cross the finish line. Running on Team Joslin for the second year in a row has allowed me to elevate the awareness of this great organization and educate people on what diabetes is all about, and how it can be prevented and treated. I credit the education, passion and mission of Joslin for helping me not miss a step on my way to Boston number 20.

Ryans goal is to raise $10,000 for Joslins High Hopes Fund. For more information or to donate, visit Ryans CrowdRise page: https://www.crowdrise.com/JoslinDiabetesCenterBoston2017/fundraiser/ryanenright.

See the article here:
Hingham man running 20th consecutive marathon despite diabetes - Wicked Local Hingham

This entry was posted on April 3, 2017 at 3:47 am and is filed under Diabetes. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |